Hollings collaborates on two studies showing how to boost immunotherapy effectiveness for patients with oral-cavity squamous cell carcinoma
Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell ...